Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Sussman

Neurological Surgery Hartford, CT Medical Doctor

NPI 1437569522 CMS profile 1397141

100 Retreat Ave Ste 705, Hartford, CT 06106

Open in the dashboard

General payments

$70,731

116 records reported · program years 2019–2025

Research payments

$12,500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Sussman of Hartford, CT is reported in the CMS Open Payments database as having received $70,731 across 116 general payments and $12,500 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $42,711 33
2024 General $25,051 36
2024 Research $12,500 1
2023 General $921 15
2022 General $1,909 29
2020 General $13 1
2019 General $126 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Sussman
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Eric Sussman were reported at $42,711. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Eric Sussman Neurological Surgery median Middle half National median
2019 $126 $582 $138–$3,006 $163
2020 $13 $294 $76–$2,174 $114
2021 $0 $387 $105–$2,432 $132
2022 $1,909 $542 $139–$2,989 $149
2023 $921 $534 $145–$2,697 $160
2024 $25,051 $574 $155–$3,046 $164
2025 $42,711 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $46,531 42 payments
  2. Balt USA, LLC $19,516 12 payments
  3. Silk Road Medical, Inc. $1,479 5 payments
  4. Stryker Corporation $1,210 28 payments
  5. DePuy Synthes Sales Inc. $883 13 payments
  6. MicroVention, Inc. $291 4 payments
  7. Route 92 Medical, Inc. $154 1 payment
  8. Medtronic, Inc. $148 1 payment
  9. Medtronic USA, Inc. $139 3 payments
  10. LifeNet Health $100 1 payment
  11. Other $281 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $53,348 16 payments
  2. Travel and Lodging $12,960 27 payments
  3. Food and Beverage $4,402 72 payments
  4. Education $20 1 payment
Products named General payments · program years 2019–2025
  1. EMBOGUARD $34,179 19 payments
  2. Optima Coil System $19,977 14 payments
  3. Spotlight $8,000 2 payments
  4. ENROUTE Transcarotid Stent $1,479 5 payments
  5. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $1,479 5 payments
  6. CEREPAK UNIFORM $1,416 12 payments
  7. ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter $1,366 4 payments
  8. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $1,366 4 payments
  9. EVEREST SPINAL SYSTEM $948 24 payments
  10. TRUFILL $938 4 payments
  11. Other $3,302 39 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Nuvascular Inc. $12,500 1 payment

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$98,436

Medicare's payments for the services billed

Medicare patients

132

Average age 74

Services billed

446

73 women, 59 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Ischemic heart disease 36%
Diabetes 33%
Depression 31%
Atrial fibrillation 27%
Chronic kidney disease 23%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

117 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record